These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6150492

  • 1. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
    Borsetti G, Rocco P, Spilimbergo PG, Giavedoni A, Frangiamone L, Beccaceci A, Judice A, Cisternino M, Volterra V.
    Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
    [Abstract] [Full Text] [Related]

  • 2. Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients.
    Viswanathan R, Rajhkowa S.
    Pharmatherapeutica; 1982; 3(2):93-9. PubMed ID: 7100227
    [Abstract] [Full Text] [Related]

  • 3. A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.
    Carney MW.
    Pharmatherapeutica; 1984; 4(1):57-63. PubMed ID: 6150493
    [Abstract] [Full Text] [Related]

  • 4. An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia.
    Kazi HA.
    Pharmatherapeutica; 1986; 4(9):555-60. PubMed ID: 3763650
    [Abstract] [Full Text] [Related]

  • 5. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA.
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [Abstract] [Full Text] [Related]

  • 6. Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot.
    Dom R, De Mesmaecker L, van den Broucke M, van Hest T, Baro F.
    Acta Psychiatr Scand; 1978 Apr; 57(4):299-304. PubMed ID: 352094
    [Abstract] [Full Text] [Related]

  • 7. Clopenthixol decanoate in schizophrenia.
    Carney MW, Rutherford P.
    Curr Med Res Opin; 1981 Apr; 7(4):205-11. PubMed ID: 6112116
    [Abstract] [Full Text] [Related]

  • 8. A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness.
    Mann BS, Moslehuddin KS, Owen RT, Clayton AR, Rohatgi KK, Sud P, Vaddadi KS.
    Pharmatherapeutica; 1985 Apr; 4(6):387-92. PubMed ID: 2867559
    [Abstract] [Full Text] [Related]

  • 9. [cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
    Sieberns S, Spechtmeyer H.
    Int Pharmacopsychiatry; 1982 Apr; 17(3):170-84. PubMed ID: 7141812
    [Abstract] [Full Text] [Related]

  • 10. Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study.
    Wistedt B, Koskinen T, Thelander S, Nerdrum T, Pedersen V, Mølbjerg C.
    Acta Psychiatr Scand; 1991 Jul; 84(1):14-21. PubMed ID: 1681680
    [Abstract] [Full Text] [Related]

  • 11. [A 1-year experience with the administration of clopenthixol decanoate in schizophrenic psychoses].
    Svestka J, Náhunek K, Cesková E, Rysánek R.
    Cesk Psychiatr; 1984 Jun; 80(3):146-54. PubMed ID: 6148152
    [No Abstract] [Full Text] [Related]

  • 12. Open clinical study of cis(Z)-clopenthixol.
    Sechter D, Caillard V, Cuche H, Deniker P.
    Acta Psychiatr Scand Suppl; 1981 Jun; 294():20-4. PubMed ID: 6951393
    [Abstract] [Full Text] [Related]

  • 13. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
    Ahlfors UG, Dencker SJ, Gravem A, Remvig J.
    Acta Psychiatr Scand Suppl; 1980 Jun; 279():77-91. PubMed ID: 6996426
    [Abstract] [Full Text] [Related]

  • 14. [A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials].
    Lambert PA, Chabannes JP.
    Encephale; 1984 Jun; 10(2):83-91. PubMed ID: 6381033
    [Abstract] [Full Text] [Related]

  • 15. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
    Izmeth MG, Khan SY, Kumarajeewa DI, Shivanathan S, Veall RM, Wiley YV.
    Pharmatherapeutica; 1988 Jun; 5(4):217-27. PubMed ID: 2902642
    [Abstract] [Full Text] [Related]

  • 16. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales.
    Bobon D, Troisfontaines B, Kempeneers JL, Xhenseval B, Bourdouxhe S, Mirel J, Gilson H, Toussaint C, von Frenckell R, Pedersen V.
    Acta Psychiatr Belg; 1986 Jun; 86(2):152-76. PubMed ID: 2873713
    [Abstract] [Full Text] [Related]

  • 17. Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate.
    Szukalski B, Lipska B, Welbel L, Nurowska K.
    Psychopharmacology (Berl); 1986 Jun; 89(4):428-31. PubMed ID: 2875481
    [Abstract] [Full Text] [Related]

  • 18. Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo.
    Balant LP, Balant-Gorgia AE, Eisele R, Reith B, Gex-Fabry M, Garrone G.
    Pharmacopsychiatry; 1989 Nov; 22(6):250-4. PubMed ID: 2575763
    [Abstract] [Full Text] [Related]

  • 19. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
    Heikkilä L, Laitinen J, Vartiainen H.
    Acta Psychiatr Scand Suppl; 1981 Nov; 294():30-8. PubMed ID: 7041517
    [Abstract] [Full Text] [Related]

  • 20. [Maintenance therapy using clopenthixol decanoate in schizophrenic patients].
    Kabes J, Balon R, Papezová H.
    Cesk Psychiatr; 1986 Aug; 82(3-4):189-94. PubMed ID: 3769007
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.